- Home
- FOA vs CMPX Comparison
FOA vs CMPX Comparison
Compare FOA & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOA
- CMPX
- Stock Information
- Founded
- FOA 2013
- CMPX 2014
- Country
- FOA United States
- CMPX United States
- Employees
- FOA N/A
- CMPX N/A
- Industry
- FOA Finance Companies
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- FOA Finance
- CMPX Health Care
- Exchange
- FOA Nasdaq
- CMPX Nasdaq
- Market Cap
- FOA 240.8M
- CMPX 206.3M
- IPO Year
- FOA N/A
- CMPX N/A
- Fundamental
- Price
- FOA $25.24
- CMPX $1.39
- Analyst Decision
- FOA Hold
- CMPX Strong Buy
- Analyst Count
- FOA 1
- CMPX 3
- Target Price
- FOA $24.00
- CMPX $7.67
- AVG Volume (30 Days)
- FOA 155.6K
- CMPX 450.8K
- Earning Date
- FOA 11-06-2024
- CMPX 11-12-2024
- Dividend Yield
- FOA N/A
- CMPX N/A
- EPS Growth
- FOA N/A
- CMPX N/A
- EPS
- FOA 10.89
- CMPX N/A
- Revenue
- FOA $719,526,000.00
- CMPX $850,000.00
- Revenue This Year
- FOA N/A
- CMPX N/A
- Revenue Next Year
- FOA N/A
- CMPX $610.48
- P/E Ratio
- FOA $2.01
- CMPX N/A
- Revenue Growth
- FOA 3011.46
- CMPX N/A
- 52 Week Low
- FOA $4.10
- CMPX $0.77
- 52 Week High
- FOA $28.50
- CMPX $2.34
- Technical
- Relative Strength Index (RSI)
- FOA 57.61
- CMPX 42.05
- Support Level
- FOA $23.46
- CMPX $1.33
- Resistance Level
- FOA $28.50
- CMPX $1.58
- Average True Range (ATR)
- FOA 2.70
- CMPX 0.12
- MACD
- FOA -0.01
- CMPX -0.02
- Stochastic Oscillator
- FOA 54.06
- CMPX 18.09
About FOA Finance of America Companies Inc.
Finance of America Companies Inc is a financial services holding company that, through its operating subsidiaries, is a modern retirement solutions platform that provides customers with access to an range of retirement offerings centered on the home. In addition, FoA offers capital markets and portfolio management capabilities to optimize the distribution of its originated loans to investors. It operates through two segments: Retirement Solutions and Portfolio Management. It generates the majority of its revenue from Retirement Solutions.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.